Author Search Results

1

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX

by Wulffraat NM, Rademaker C, Sinnema G, Bulatović M, Verkaaik M
Published 2011-09-01

Article

2

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis

by Heijstek MW, Berbers GAM, van Gageldonk PGM, Uiterwaal CSP, Wulffraat NM
Published 2008-09-01

Article

3

Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis

by Heijstek MW, Wulffraat NM, Eken Y, Pluijm SMF, Rademaker CMA, de Jonge R
Published 2008-09-01

Article

4

4.5 Defective phosphorylation of the interleukin 18 receptor beta-chain causes impaired NK cell function in systemic onset Juvenile Idiopathic Arthritis

by de Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, Prakken BJ
Published 2008-09-01

Article

5

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases

by van der Klis F, Berbers G, Tacke C, Scherpenisse M, Groot N, Heijstek MW, Wulffraat NM
Published 2011-09-01

Article

6

Mesenchymal stem cells and JIA

by Slaper-Cortenbach I, Martens AC, Prakken BJ, Kuis W, Hofhuis F, de Roock S, Swart JF, Wulffraat NM
Published 2011-09-01

Article

7

2.5 Mesenchymal Stem Cell Therapy has significant clinical effect in proteoglycan induced arthritis

by Swart JF, Backer MJG, Hofhuis F, de Jager W, Prakken BJ, Kuis W, Martens ACM, Wulffraat NM
Published 2008-09-01

Article

8

Etanercept in juvenile idiopathic arthritis: Who will benefit?

by van den Berg JM, Swart JF, Dolman KM, Gorter SL, Koopman-Keemink Y, Twilt M, Hoppenreijs EPAH, ten Cate R, Armbrust W, Prince FHM, Otten MH, Wulffraat NM, van Rossum MAJ, van Suijlekom-Smit LWA
Published 2011-09-01

Article

9

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a...

by McCann L, Ozdogan H, Rutkowska-Sak L, Ferrandiz MA, Wulffraat NM, Brik R, Kallinich T, Erguven M, Berkun Y, Constantin T, Quartier P, Horneff G, Brunner H, Ruperto N, Lheritier K, Preiss R, Tseng L, Martini A, Lovell DJ
Published 2011-09-01

Article

10

Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases

by Aeschlimann, F.A, Belot, A., Berkun, Y., Chang, M.-L, Clemente, D., Costello, R., Dackhammar, C., Eulert, S., Fingerhutová, S., Hyrich, K.L, Kallinich, T., Kearsley-Fleet, L., Koné-Paut, I., Lawson-Tovey, S., Machado, P.M, Mateus, E.F, Melki, I., Natter, M., Oliveira Ramos, F., Raffeiner, B., Strangfeld, A., Švestková, N., Uziel, Y., Waite, H., Wulffraat, N.M
Published 2022

View Fulltext in Publisher

Article

Related Subjects